Document is current
Any future updates will be listed below
-
Authors
Khor, Bernard
Spinazzi, Noemi A.
Patel, Lina R.
Chelales, Erika
Baumer, Nicole
Bulova, Peter
Chicoine, Brian
Borzutzky, Arturo
El Sahly, Hana M.
Espinosa, Joaquin M.
Gans, Melissa D.
McCormick, Andrew A.
Partridge, Rebecca
Rubenstein, Eric
Santoro, Jonathan D.
Speake, Cate
Camacho, Juanita Valdes
Vellody, Kishore
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01-AI166835)
National Institutes of Health (R01 AI150305)
- License Information
-
More Information
Article History
Received: 18 February 2026
Accepted: 11 May 2026
First Online: 19 May 2026
Competing interests
: Author BK has previously acted as a paid consultant for Pfizer, Teraimmune and Fresh Track Therapeutics, but declares no non-financial competing interests. Authors NS and NB have previously acted as paid members of a safety monitoring advisory board for Ionis Pharmaceuticals; they declare no non-financial competing interests. All other authors declare no financial or non-financial competing interests.
